Stroke treatment developer Silk Road Medical (NSDQ:SILK) announced that it appointed a new executive VP of R&D and COO. William Whealon joined as executive VP of research & development, effective immediately, while current CFO Lucas Buchanan will also operate as Silk Road’s COO, effective Oct. 1. Whealon has over two decades of experience in the industry, having […]
Siemens, Novartis team up on MS drug development
Siemens Healthineers (ETR:SHL) and Novartis (NYSE:NVS) have agreed to jointly design, develop and commercialize diagnostic tests for therapeutic products across Novartis’ therapeutic pipeline, the companies announced today. The first project will be a serum neurofilament light chain (NfL) immunoassay for patients with multiple sclerosis (MS) and other neurological diseases. Get the full story on our sister site, Drug […]
RapidAI raises $25M Series B
RapidAI announced today that it raised $25 million in a Series B financing round as it looks to accelerate global growth initiatives. Lennertz & Co. contributed the funds in the financing round, with its managing director Philipp Lennertz saying in a news release that RapidAI’s work has brought “measurable improvement” to patient care around the […]
Cala Health touts results of real-world tremor study
Cala Health today touted data demonstrating that its Cala Trio therapy is safe and effective in improving essential tremor in patients. Burlingame, Calif.-based Cala Health said in a news release that the data for the wearable technology came from use at home, unsupervised and under real-world conditions, further validating the results reported in the Prospect […]
CarThera collects $14.3M
CarThera announced today that it received a $2.3 million (€2 million) grant and $12 million (€10.5 million) in equity, totaling $14.3 million. Paris-based CarThera was selected by the EIC Accelerator Pilot to receive the funds as it develops its Domeus project for treating glioblastoma patients. In addition to the money, CarThera is also slated to […]
BrainGate donates brain-computer tech to Tufts
Tufts University and alumnus Jeff Stibel announced the donation of BrainGate and its patented brain-computer technology to the university. BrainGate develops neurotechnology that uses micro-electrodes implanted in the brain to let humans operate external devices such as computers or robotic arms with just their thought, according to a news release. The company has received FDA investigational device […]
Boston Scientific launches Vercise Genus DBS system in Europe
Boston Scientific (NYSE:BSX) announced that it received CE Mark for its fourth-generation Vercise Genus deep brian stimulation system. Vercise Genus includes full-body MRI conditional and Bluetooth capabilities within a DBS system designed for treating the symptoms of Parkinson’s disease, essential tremor and dystonia by delivering electrical stimulation to targeted parts of the brain. Marlborough, Mass.-based Boston […]
Minnetronix Medical wins FDA clearance for neurosurgical access port
The FDA has cleared Minnetronix Medical‘s MindsEye neurosurgical access port for deep brain surgeries, the company announced today. The clearance represents an expansion beyond the St. Paul, Minn.–based contract manufacturer’s traditional offerings. “This extension of our business represents an additional way to partner with customers. We have the opportunity to offer them products they can […]
Theranica lands CE mark for migraine device
Theranica announced today that it received CE Mark approval for its Nerivio device for the acute treatment of migraine. Montclair, N.J.-based Theranica adds European approval just over a year since it received FDA de novo clearance for the neurostimulation device in May 2019. The approval allows for the company to begin marketing the device in […]
UK recommends Axonics SNM for overactive bladder
Axonics Modulation Technologies (NSDQ:AXNX) announced today that NICE suggested using its r-SNM system in the UK. The National Institute for Health and Care Excellence (NICE) offers evidence-based guidance to the UK and, in guidance published last week, it recommended Axonics’ sacral neuromodulation (SNM) system for treating refractory overactive bladder for the country’s National Health Service (NHS). […]
The top 5 MassDevice stories of the week — September 4, 2020
Medtronic (NYSE:MDT) and a major development involving medtech reimbursement dominated medical device industry news over the past week. As the week closes out, there’s also a trending story on MassDevice that includes good news: Abbott (NYSE:ABT) is reportedly hiring 2,000 new employees in Illinois to increase manufacturing for its rapid COVID-19 test. Want to hear more about […]
- 1
- 2
- 3
- …
- 77
- Next Page »
